Home › Funds › D. E. Shaw & Co › EBAC

D. E. Shaw & Co position in EBAC

EUROPEAN BIOTECH ACQUTN CORP

Latest position (Q4 2022)408.57K sh
Reported value held$4.13M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 229.03K $2.21M New
Q4 2021 394.16K $3.82M Add
Q1 2022 258.17K $2.52M Reduce
Q2 2022 258.17K $2.52M Hold
Q3 2022 258.57K $2.56M Hold
Q4 2022 408.57K $4.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding EBAC

No other tracked fund reports a position in EBAC.

All EBAC fund holders →